These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17936616)

  • 21. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.
    Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI
    Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oestrogen producing enzymes and mammary carcinogenesis: a review.
    Subramanian A; Salhab M; Mokbel K
    Breast Cancer Res Treat; 2008 Sep; 111(2):191-202. PubMed ID: 17934808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells.
    Brooks JD; Thompson LU
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):461-7. PubMed ID: 15876411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phytoestrogens and breast cancer: a complex story.
    Helferich WG; Andrade JE; Hoagland MS
    Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethanolic extracts of black cohosh (Actaea racemosa) inhibit growth and oestradiol synthesis from oestrone sulphate in breast cancer cells.
    Rice S; Amon A; Whitehead SA
    Maturitas; 2007 Apr; 56(4):359-67. PubMed ID: 17125943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
    Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
    Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know.
    Velentzis LS; Woodside JV; Cantwell MM; Leathem AJ; Keshtgar MR
    Eur J Cancer; 2008 Sep; 44(13):1799-806. PubMed ID: 18614351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Mechanisms of Anticancer Effects of Phytoestrogens in Breast Cancer.
    Hsieh CJ; Hsu YL; Huang YF; Tsai EM
    Curr Protein Pept Sci; 2018; 19(3):323-332. PubMed ID: 28079011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.
    Hirsch K; Atzmon A; Danilenko M; Levy J; Sharoni Y
    Breast Cancer Res Treat; 2007 Aug; 104(2):221-30. PubMed ID: 17051425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells.
    Cappelletti V; Miodini P; Di Fronzo G; Daidone MG
    Int J Oncol; 2006 May; 28(5):1185-91. PubMed ID: 16596234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global gene expression profiles induced by phytoestrogens in human breast cancer cells.
    Dip R; Lenz S; Antignac JP; Le Bizec B; Gmuender H; Naegeli H
    Endocr Relat Cancer; 2008 Mar; 15(1):161-73. PubMed ID: 18310284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy.
    Hayashi S; Yamaguchi Y
    J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):201-6. PubMed ID: 18424035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy.
    Amaral C; Varela C; Azevedo M; da Silva ET; Roleira FM; Chen S; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2013 May; 135():51-9. PubMed ID: 23318878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
    Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceutical prospects of phytoestrogens.
    Usui T
    Endocr J; 2006 Feb; 53(1):7-20. PubMed ID: 16543667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phytoestrogens, novel dietary supplements for breast cancer.
    Huang S; Qi B; Yang L; Wang X; Huang J; Zhao Y; Hu Y; Xiao W
    Biomed Pharmacother; 2023 Apr; 160():114341. PubMed ID: 36753952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engagement of phytoestrogens in breast cancer suppression: Structural classification and mechanistic approach.
    Tanwar AK; Dhiman N; Kumar A; Jaitak V
    Eur J Med Chem; 2021 Mar; 213():113037. PubMed ID: 33257172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis.
    Pelekanou V; Leclercq G
    Int J Dev Biol; 2011; 55(7-9):869-78. PubMed ID: 22161842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
    Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
    Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.